Manouchehr Saljoughian

Moraga

Contributing Editor at U.S. Pharmacist

Featured in: Favicon

uspharmacist.com

Articles

Managing Peyronie’s Disease

2 weeks ago | uspharmacist.com | Manouchehr Saljoughian

US Pharm. 2025;50(6):24-27. Peyronie’s disease (PD) is a medical condition characterized by the development of scar tissue on the penis that can cause curvature and, in some cases, painful erections. The condition was first described in 1743 by François Gigot de La Peyronie, a surgeon to King Louis XV of France.1 PD involves a disorganized deposition of collagen in the tunica albuginea. This scar tissue, or “plaque,” can lead to penile deformities.
Exploring Cannabis for Chronic Pain Treatment

Mar 14, 2025 | uspharmacist.com | Manouchehr Saljoughian

US Pharm. 2025;50(3):46-48. Cannabis has been used as medicine worldwide for over a century. As the United States and other countries allow medical and recreational cannabis use, more people are turning to cannabis to treat pain.
Advancing Ataxia Awareness

Jan 15, 2025 | uspharmacist.com | Manouchehr Saljoughian

US Pharm. 2025;50(1):23-25. Ataxia is a neurologic condition that causes loss of muscle coordination and balance, leading to abnormal muscle movements.1 It is a clinical finding rather than a specific disease and typically presents with gait abnormalities, speech changes, and irregular eye movements (nystagmus). The condition stems from dysfunction in brain areas that are responsible for movement coordination. Ataxia can be classified in two ways.
Metabolic Syndrome and Diabetes Risk

Nov 14, 2024 | uspharmacist.com | Manouchehr Saljoughian

US Pharm. 2024;49(11):10-12. Metabolic syndrome refers to the presence of a cluster of risk factors specific for developing type 2 diabetes (T2D). Individuals with metabolic syndrome have a five times greater risk of developing diabetes than the general population.
The Xylazine Public Health Emergency

Oct 17, 2024 | uspharmacist.com | Manouchehr Saljoughian

US Pharm. 2024;49(10):24-27. Xylazine is a nonnarcotic compound or tranquilizer that is used for pain and is FDA approved for use in veterinary medicine. It is also utilized for sedation and muscle relaxation in veterinary medicine, where it is often referred to as “horse anesthetic.” Xylazine is chemically known as N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine and is a clonidine analogue.
Group A Streptococcus Treatment and Management

Aug 16, 2024 | uspharmacist.com | Manouchehr Saljoughian

US Pharm. 2024;49(8):46-48. Streptococcal pharyngitis, also referred to as strep throat, is one of the most common upper respiratory infections in school-age children and young adults. In the United States, strep throat accounts for approximately 12 million visits annually in outpatient care settings.1 Strep throat is caused by both viruses and bacteria.
Male Factor Infertility

Jun 14, 2024 | uspharmacist.com | Manouchehr Saljoughian

US Pharm. 2024;49(6):24-27. Infertility is a disease of the reproductive system that can result in a man, a woman, or both having the inability to conceive a baby. Male infertility means that a male has a problem with his reproductive organs and cannot achieve a pregnancy with a female partner. Problems with producing healthy sperm are the most common causes of male infertility.
COVID-19 Vaccines Past and Present

Apr 18, 2024 | uspharmacist.com | Manouchehr Saljoughian

US Pharm. 2024;49(4):30-31. COVID-19 is a coronavirus that spreads primarily from close contact with another individual with COVID-19. People are typically infected from the respiratory droplets of infected people.
Combating Sepsis

Feb 15, 2024 | uspharmacist.com | Manouchehr Saljoughian

US Pharm. 2024;49(2):27-29. Sepsis is a potentially life-threatening condition. It is a serious infection resulting from the presence of harmful bacteria in the blood or other tissues. The body’s reaction to this condition can lead to the malfunctioning of various organs, shock, and death.1 Bacterial infections cause most cases of sepsis.
Influenza Vaccine Update

Dec 19, 2023 | uspharmacist.com | Manouchehr Saljoughian

US Pharm. 2023;48(12):36-37. Influenza, also known as the flu, is a contagious disease that is caused by influenza viruses. Influenza viruses infect the respiratory tract (i.e., nose, throat, and lungs). The flu shot (vaccine) protects people against the influenza virus infection. The CDC recommends that adults receive the annual flu shot in September or October. Children aged younger than 8 years who need two doses of the vaccine should get the first in the series in July or August.